Biota Scientific Management is a wholly subsidiary of an Australia-based anti-infective drug developer, Biota.
As part of this 5-year grant funding, the company expects to receive $830,287 in the first year.
Future payments to Biota are subject to satisfactory project progress and the availability of funding.